世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

無細胞RNA単離・抽出キット市場 - 世界の産業規模、シェア、動向、機会、予測、2017-2027用途別(腫瘍学、出生前スクリーニング、代謝性疾患、その他)、エンドユーザー別(病院・クリニック、製薬・バイオテクノロジー企業、その他)、企業別、地域別


Cell Free RNA Isolation & Extraction Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027Segmented By Application (Oncology, Prenatal Screening, Metabolic Disorders, Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), By Company, and By Region

世界の無細胞RNA分離・抽出キット市場は、2023-2027年の予測期間中に目覚ましい成長を遂げると予測されている。主な要因としては、様々な種類の癌の発生率の上昇や出生前合併症の症例数の増加が挙げられ、これら... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年8月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
112 英語

 

サマリー

世界の無細胞RNA分離・抽出キット市場は、2023-2027年の予測期間中に目覚ましい成長を遂げると予測されている。主な要因としては、様々な種類の癌の発生率の上昇や出生前合併症の症例数の増加が挙げられ、これらは市場の成長を後押ししている。無細胞RNA分離抽出キット市場は、医療の意思決定に不可欠な市場として確立されており、幅広い治療普及のための情報取得を助け、医療における重要性を強調している。市場の成長を支えるその他の要因としては、高齢者人口の増加、広範な研究開発、非侵襲的・低侵襲的方法に関する患者集団の意識、政府投資の増加、技術の進歩などが挙げられる。また、バイオテクノロジー企業や製薬企業による戦略的提携や協力関係も市場の成長を後押ししている。
がんの発生率の増加
人口の間で肺がん、子宮頸がん、乳がんなどのがんの発生が増加していることが、市場成長の一因となっている。がんは、世界中で死亡率および身体障害の2番目に大きな原因であると考えられている。無細胞RNAは無細胞液中に存在し、腫瘍脱落率の低い患者の腫瘍を検出する機会となる。例えば、2020年に国際がん研究機関(IARC)から発表されたデータでは、生涯で5人に1人ががんに罹患し、世界全体で男性の8人に1人、女性の11人に1人ががんで死亡していることが明らかになった。その改訂版GLOBOCAN 2020報告書によれば、全世界でおよそ1930万人のがん患者が新たに登録され、1000万人ががんで死亡している。したがって、がんに罹患する患者数の増加が、無細胞RNA分離抽出キット市場の成長を後押ししている。
出生前の合併症の症例数の増加
過去数年の間に、出生前合併症の予測に役立つ無細胞RNAのような非侵襲的技術の応用において急速な進歩が見られた。子宮内発育制限(IUGR)、子癇前症、自然早産(PTB)などの出生前合併症は、無細胞RNA(cf RNA)によって特徴づけられ、予測することができる。例えば、2014年から2018年の間に、妊娠合併症率は16%以上上昇し、出産合併症率は14%以上上昇した。1,000人の妊婦のうち約7人が妊娠糖尿病と子癇前症の合併症にかかっており、2014年から31%近く増加している。したがって、出産前合併症に苦しむ女性の増加に起因して、無細胞RNA分離抽出キットに対する需要の急増が市場の成長を促進している。
市場区分
世界の無細胞RNA分離・抽出キット市場は、用途、エンドユーザー、企業に区分される。用途に基づき、市場は腫瘍学、出生前スクリーニング、代謝性疾患、その他に分けられる。エンドユーザーに基づけば、市場は病院&クリニック、製薬&バイオテクノロジー企業、その他に区分される。国別では、米国は癌の有病率が上昇しているため、予測期間中に有利な市場になると予想される。
市場プレイヤー
F.Hoffmann-La Roche AG、JBS Science Inc.、Aline Biosciences、Apostle Inc.(アポストル・サイエンシズ)、Danagen-Bioted, S.L.、Norgen Biotek Corp.、PerkinElmer, Inc.、Promega Corporation、QIAGEN N.V.、Thermo Fisher Scientific Inc.などは、この市場で事業を展開している大手企業である。
レポートの範囲
本レポートでは、世界の無細胞RNA単離・抽出キット市場を、業界動向に加えて以下のカテゴリーに分類し、その詳細も記載しています:
- 無細胞RNA分離・抽出キット市場、用途別
o 腫瘍学
o 出生前スクリーニング
o 代謝障害
o その他
- 無細胞RNA分離抽出キット市場:エンドユーザー別
o 病院・クリニック
o 製薬・バイオテクノロジー企業
o その他
- 無細胞RNA分離抽出キット市場:地域別
o 北米
 米国
 カナダ
 メキシコ
o アジア太平洋
 中国
 インド
 日本
 オーストラリア
 韓国
ヨーロッパ & CIS
 ドイツ
 フランス
 イギリス
 スペイン
 イタリア
o 南米
 ブラジル
 アルゼンチン
 コロンビア
o 中東・アフリカ
 南アフリカ
 サウジアラビア
 UAE
 エジプト
 トルコ
競争状況
企業プロフィール:無細胞RNA分離・抽出キット市場に参入している主要企業の詳細分析
利用可能なカスタマイズ:
TechSci Research社は、与えられた市場データをもとに、企業の特定のニーズに応じてカスタマイズを提供します。本レポートでは以下のカスタマイズが可能です:
企業情報
- 追加市場参入企業(最大5社)の詳細分析とプロファイリング

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Cell Free RNA Isolation & Extraction Kits Market
5. Voice of Customer
6. Global Cell Free RNA Isolation & Extraction Kits Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application (Oncology, Prenatal Screening, Metabolic Disorders, Others)
6.2.2. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
6.2.3. By Company (2021)
6.2.4. By Region
6.3. Market Map
7. North America Cell Free RNA Isolation & Extraction Kits Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By End User
7.2.3. By Country
7.3. North America: Country Analysis
7.3.1. United States Cell Free RNA Isolation & Extraction Kits Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By End User
7.3.2. Canada Cell Free RNA Isolation & Extraction Kits Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By End User
7.3.3. Mexico Cell Free RNA Isolation & Extraction Kits Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By End User
8. Europe Cell Free RNA Isolation & Extraction Kits Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By End User
8.2.3. By Country
8.3. Europe: Country Analysis
8.3.1. France Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By End User
8.3.2. Germany Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By End User
8.3.3. United Kingdom Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By End User
8.3.4. Italy Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By End User
8.3.5. Spain Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By End User
9. Asia-Pacific Cell Free RNA Isolation & Extraction Kits Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By End User
9.2.3. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By End User
9.3.2. India Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By End User
9.3.3. Japan Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By End User
9.3.4. South Korea Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Application
9.3.4.2.2. By End User
9.3.5. Australia Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Application
9.3.5.2.2. By End User
10. South America Cell Free RNA Isolation & Extraction Kits Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By End User
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cell Free RNA Isolation & Extraction Kits Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By End User
10.3.2. Argentina Cell Free RNA Isolation & Extraction Kits Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By End User
10.3.3. Colombia Cell Free RNA Isolation & Extraction Kits Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By End User
11. Middle East and Africa Cell Free RNA Isolation & Extraction Kits Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Application
11.2.2. By End User
11.2.3. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Application
11.3.1.2.2. By End User
11.3.2. Saudi Arabia Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Application
11.3.2.2.2. By End User
11.3.3. UAE Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Application
11.3.3.2.2. By End User
11.3.4. Turkey Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Application
11.3.4.2.2. By End User
11.3.5. Egypt Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Application
11.3.5.2.2. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. F.Hoffmann-La Roche AG
14.2. JBS Science Inc.
14.3. Aline Biosciences
14.4. Apostle Inc. (Apostle Sciences)
14.5. Danagen-Bioted, S.L.
14.6. Norgen Biotek Corp.
14.7. PerkinElmer, Inc.
14.8. Promega Corporation
14.9. QIAGEN N.V.
14.10. Thermo Fisher Scientific Inc.
15. Strategic Recommendations

 

ページTOPに戻る


 

Summary

The global cell-free RNA isolation & extraction kits market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rising incidences of different types of cancer and a growing number of cases of prenatal complications, which are bolstering the growth of the market. The cell-free RNA isolation and extraction kits market is a well-established market with an integral part of medical decision-making, which aids in obtaining information for a wide range of treatment dissemination, emphasizing their cruciality in healthcare. The other factors supporting the market’s growth are the rising geriatric population base, extensive research, and development, awareness among the patient population about non-invasive and minimally invasive methods, increasing government investments, and technological advancements. Also, strategic partnerships and collaborations by biotechnology and pharmaceutical companies are fueling the growth of the market.
Increasing Incidence of Cancer
The growing occurrences of cancer, such as lung cancer, cervical cancer, breast cancer, and others among the population, is a contributing factor to the growth of the market. Cancer is considered the second largest cause of mortality and disability across the globe. Cell-free RNA occurs in cell-free fluids and is an opportunity to detect tumors in patients with lower tumor-shedding rates. For instance, in 2020, data was released by the International Agency for Research on Cancer (IARC), which revealed that 1 in 5 people develop cancer in their lifetime, and 1 in 8 men and 1 in 11 women die from cancer globally. As per its revised GLOBOCAN 2020 report, roughly 19.3 million new cancer cases were registered, and 10 million people died from it across the globe. Thus, the increase in the number of patients suffering from cancer is bolstering the growth of the Cell-Free RNA Isolation & Extraction Kits Market.
Increasing Number of Cases with Prenatal Complications
Over the past few years, rapid advancements have been made in the application of non-invasive techniques such as cell-free RNA, which helps to predict prenatal complications. Prenatal complications such as intrauterine growth restriction (IUGR), preeclampsia, and spontaneous preterm birth (PTB) can be characterized and predicted by cell-free RNA (cf RNA). For instance, between 2014-2018, the pregnancy complications rates rose more than 16%, while childbirth complications rates rose more than 14%. Around seven out of every 1,000 pregnant women underwent gestational diabetes and preeclampsia complications, an almost 31% increase since 2014. Therefore, owing to the increase in the number of women suffering from prenatal complications, the surge in demand for cell-free RNA isolation and extraction kits is fueling the growth of the market.
Market Segmentation
The global cell-free RNA isolation & extraction kits market is segmented into application, end user, and company. Based on application, the market is divided into oncology, prenatal screening, metabolic disorders, and others. Based on end users, the market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising prevalence of cancer in the country.
Market Players
F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. are some of the leading companies operating in the market.
Report Scope:
In this report, global cell-free RNA isolation & extraction kits market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
• Cell Free RNA Isolation & Extraction Kits Market, By Application:
o Oncology
o Prenatal Screening
o Metabolic Disorders
o Others
• Cell Free RNA Isolation & Extraction Kits Market, By End User:
o Hospitals & Clinics
o Pharmaceutical & Biotechnology Companies
o Others
• Cell Free RNA Isolation & Extraction Kits Market, By Region:
o North America
 United States
 Canada
 Mexico
o Asia-Pacific
 China
 India
 Japan
 Australia
 South Korea
o Europe & CIS
 Germany
 France
 United Kingdom
 Spain
 Italy
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Egypt
 Turkey
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in cell free RNA isolation & extraction kits market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Cell Free RNA Isolation & Extraction Kits Market
5. Voice of Customer
6. Global Cell Free RNA Isolation & Extraction Kits Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application (Oncology, Prenatal Screening, Metabolic Disorders, Others)
6.2.2. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
6.2.3. By Company (2021)
6.2.4. By Region
6.3. Market Map
7. North America Cell Free RNA Isolation & Extraction Kits Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By End User
7.2.3. By Country
7.3. North America: Country Analysis
7.3.1. United States Cell Free RNA Isolation & Extraction Kits Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By End User
7.3.2. Canada Cell Free RNA Isolation & Extraction Kits Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By End User
7.3.3. Mexico Cell Free RNA Isolation & Extraction Kits Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By End User
8. Europe Cell Free RNA Isolation & Extraction Kits Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By End User
8.2.3. By Country
8.3. Europe: Country Analysis
8.3.1. France Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By End User
8.3.2. Germany Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By End User
8.3.3. United Kingdom Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By End User
8.3.4. Italy Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By End User
8.3.5. Spain Cell Free RNA Isolation & Extraction Kits Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By End User
9. Asia-Pacific Cell Free RNA Isolation & Extraction Kits Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By End User
9.2.3. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By End User
9.3.2. India Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By End User
9.3.3. Japan Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By End User
9.3.4. South Korea Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Application
9.3.4.2.2. By End User
9.3.5. Australia Cell Free RNA Isolation & Extraction Kits Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Application
9.3.5.2.2. By End User
10. South America Cell Free RNA Isolation & Extraction Kits Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By End User
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cell Free RNA Isolation & Extraction Kits Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By End User
10.3.2. Argentina Cell Free RNA Isolation & Extraction Kits Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By End User
10.3.3. Colombia Cell Free RNA Isolation & Extraction Kits Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By End User
11. Middle East and Africa Cell Free RNA Isolation & Extraction Kits Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Application
11.2.2. By End User
11.2.3. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Application
11.3.1.2.2. By End User
11.3.2. Saudi Arabia Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Application
11.3.2.2.2. By End User
11.3.3. UAE Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Application
11.3.3.2.2. By End User
11.3.4. Turkey Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Application
11.3.4.2.2. By End User
11.3.5. Egypt Cell Free RNA Isolation & Extraction Kits Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Application
11.3.5.2.2. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. F.Hoffmann-La Roche AG
14.2. JBS Science Inc.
14.3. Aline Biosciences
14.4. Apostle Inc. (Apostle Sciences)
14.5. Danagen-Bioted, S.L.
14.6. Norgen Biotek Corp.
14.7. PerkinElmer, Inc.
14.8. Promega Corporation
14.9. QIAGEN N.V.
14.10. Thermo Fisher Scientific Inc.
15. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

TechSci Research 社の最新刊レポート

本レポートと同じKEY WORD(oncology)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/19 10:26

158.49 円

173.02 円

207.86 円

ページTOPに戻る